The ALS Society of BC awarded $2 million for PROJECT HOPE to establish ALS research professorship at UBC
On May 12, 2021, the province of British Columbia provided the ALS Society of BC with $2 million…
-
-
INOVIO’s Pan-COVID-19 vaccine candidate (INO-4802) induces broad immunity against vviral variants in preclinical studies
On May 12, 2021, Inovio Pharma announced that its next-generation Pan-COVID-19 vaccine candidate, INO-4802, induced potent neutralizing antibodies…
-
Biotechnology | COVID-19 | Diagnostics | FDA
InBios received FDA EUA for COVID-19 POC antigen detection test
On May 12, 2021, InBios announced that it had received Emergency Use Authorization from the U.S. Food and…
-
Biotechnology | COVID-19 | Diagnostics | FDA
InBios received FDA EUA for COVID-19 POC antigen detection test
On May 12, 2021, InBios announced that it had received Emergency Use Authorization from the U.S. Food and…
-
Dr. Connie Eaves was inducted into The Royal Society for her development of robust functional methods to quantify and characterize distinct types of primitive blood and mammary cell precursors.
On May 11, 2011, University of British Columbia professor Connie Eaves was inducted into The Royal Society for…
-
Novavax announced positive preclinical data for combination influenza and COVID-19 vaccine candidate
On May 10, 2021, Novavax announced data from a preclinical study of the company’s combination quadrivalent seasonal flu…
-
INOVIO announced positive data from phase 2 clinical trial evaluating INO-4800 COVID-19 DNA vaccine
On May 10, 2021, Inovio Pharma announced positive safety, tolerability and immunogenicity data from its placebo-controlled and blinded…
-
Pfizer and BioNTech received first U.S. EUA of COVID-19 vaccine in adolescents
On May 10, 2021, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) had expanded…
-
Altimmune announced preclinical data for AdCOVIDﾙ demonstrating sterilizing immunity after single intranasal dose
On May 10, 2021, Altimmune announced positive results from a preclinical study of AdCOVID in a SARS-CoV-2 challenge…
-
Gene therapy restored immune function in children with rare immunodeficiency
On May 10, 2021, the National Institutes of Health reported that an investigational gene therapy can safely restore…
-
FDA granted Fast Track Designation to CERC-002 for treatment of hospitalized patients with COVID-19
On May 10, 2021, Cerecor announced that the U.S. Food and Drug Administration (FDA) had granted Fast Track…
-
AquaBounty sold out first commercial harvest of genetically engineered Atlantic Salmon from its Indiana farm
On May 10, 2021, AquaBounty Technologies announced that purchase orders had been received for the planned harvest of…
-
WHO listed additional COVID-19 vaccine for emergency use and issues interim policy recommendations
On May 7, 2021, the World Health Organization (WHO) listed the Sinopharm COVID-19 vaccine for emergency use, giving…
-
Pfizer and BioNTech initiated rolling submission of Biologics License Application for FDA approval of COVID-19 vaccine
On May 7, 2021, Pfizer and BioNTech announced the initiation of a Biologics License Application (BLA) with the…
-
GSK and Vir Biotechnology announced start of the EMA rolling review of VIR-7831 (sotrovimab) for early treatment of COVID-19
On May 7, 2021, GlaxoSmithKline and Vir Biotechnology announced that the European Medicines Agency (EMA) has started a…
-
Novavax and Gavi executed advance purchase agreement for COVID-19 vaccine for COVAX facility
On May 6, 2021, Novavax announced that it had finalized an advance purchase agreement (APA) with Gavi, the…
-
Moderna announced agreement with Switzerland for 7 million booster vaccine doses in 2022 with options
On May 6, 2021, Moderna announced a new supply agreement with the Swiss Federal Government for 7 million…
-
Trevena announced TRV027 selected by NIH-funded ACTIV initiative for COVID-19 trial
On May 6, 2021, Trevena announced that TRV027, the Companyﾒs novel AT1 receptor selective agonist, had been selected…
-
Pfizer and BioNTech announced supplying COVID-19 vaccine for Olympic athletes at 2020 Tokyo games
On May 6, 2021, Pfizer announced the signing of a Memorandum of Understanding (MoU) with the International Olympic…
-
Humanigen reported positive phase 3 results demonstrating Lenzilumabﾙ improved survival without mechanical ventilation with COVID-19
On May 5, 2021, Humanigen announced that results from the lenzilumab Phase 3 study in hospitalized COVID-19 patients…
-
U.S. sent first flight of medical supplies to India for COVID-19 fight
On May 5, 2021, the United States sent its first flight loaded with oxygen cylinders and regulators, N95…
-
NEJM published phase 2b clinical trial results demonstrating efficacy of COVID-19 vaccine against B.1.351 variant
On May 5, 2021, Novavax announced the publication of results from the initial primary analysis of a Phase…
-
CytoDyn reaches agreement with Albert Einstein Israelite Hospital in Brazil to conduct two COVID-19 trials
On May 5, 2021, CytoDyn announced an agreement to partner with the Albert Einstein Israelite Hospital (AEIH) in…
-
Pfizer and BioNTech received Health Canada authorization of COVID-19 vaccine in adolescents
On May 5, 2021, Pfizer and BioNTech announced that Health Canada had expanded the Interim Order authorization for…
-
Moderna announced positive initial booster data against SARS-CoV-2 variants
On May 5, 2021, Moderna announced initial data from its Phase 2 study showing that a single 50…
-
WHO and Germany launched new global hub for pandemic and epidemic intelligence
On May 5, 2021, the World Health Organization (WHO) and the Federal Republic of Germany announced a new…
-
Hoth Therapeutics and Virginia Commonwealth University expanded research agreement for COVID-19 therapeutic
On May 5, 2021, Hoth Therapeutics announced it has expanded its sponsored research agreement with Virginia Commonwealth University…
-
Moderna announced expansion of its manufacturing technology center in Massachusetts
On May 4, 2021, Moderna announced an expansion of the Moderna Technology Center (MTC) in Norwood, MA including…
-
HDT Bio, Gennova Biopharma announced volunteers dosed in phase I/II trials of COVID-19 RNA vaccine in India
On May 4, 2021, HDT Bio announced that its development partner in India, Gennova Biopharmaceuticals, had begun dosing…
-
Moderna announced supply agreement with Gavi for up to 500 million doses of COVID-19 Vaccine Moderna for COVAX
On May 3, 2021, Moderna announced an agreement with Gavi, the Vaccine Alliance to supply up to 500…
